In this study, OGM detected MYCN amplification in three cell lines (NB1691, NBLW and SK-N-BE2(C)), a TERT rearrangement in one cell line (GI-ME-N) and an intragenic ATRX deletion in a NB tumour. The gene discussed is TERT; the disease is neuroblastoma.